Predictors of Vedolizumab Dose Escalation or Cessation in Inflammatory Bowel Disease Patients: 749. (October 2017) - Razvi, Mohammed A.; Chowdhury, Reezwana; Parian, Alyssa; Melia, Joanna; Truta, Brindusa; Brant, Steve; Dudley‐Brown, Sharon; Lazarev, Mark